Farishta v. Tenet Healthsystem Hospitals Dallas, Inc.

224 S.W.3d 448, 2007 WL 174417
CourtCourt of Appeals of Texas
DecidedApril 26, 2007
Docket2-06-188-CV
StatusPublished
Cited by38 cases

This text of 224 S.W.3d 448 (Farishta v. Tenet Healthsystem Hospitals Dallas, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals of Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Farishta v. Tenet Healthsystem Hospitals Dallas, Inc., 224 S.W.3d 448, 2007 WL 174417 (Tex. Ct. App. 2007).

Opinion

OPINION

BOB McCOY, Justice.

I. Introduction

In one issue, Appellant Ashraf Farishta (“Ashraf’), Individually and as Next Friend for Inaya Farishta (“Inaya”), asserts that the trial court abused its discretion, “by looking beyond the four corners of the expert reports, in [an] effort to strike [P]laintiffs expert reports under § 74.351.” See Tex. Civ. Prao. & Rem.Code Ann. § 74.351 (Vernon Supp.2006). While we are not completely certain of the meaning of this issue in the context of the briefing, we agree that the trial court must look only to the four corners of the expert report to determine its adequacy. See Bowie Mem’l Hosp. v. Wright, 79 S.W.3d 48, 52 (Tex.2002). We will construe the issue within the context of the briefing to mean the trial court abused its discretion in striking the Plaintiffs expert reports for not meeting the statutory requirements. See Tex.R.App. P. 38.9. We reverse and remand to the trial court.

II. Factual Background

This is the GBS case. Ashraf gave birth to Inaya on August 4, 2003 at Trinity Medical Center (“Trinity”). Inaya developed early onset Group B Streptococcus infection (“GBS”) at birth. As a result of Inaya’s GBS infection, she developed multiple complications including respiratory distress, cyanosis, and pneumonia requiring intubation and prolonged hospitalization.

In August of 2002, one year prior to Inaya’s birth, the United States Government’s Centers for Disease Control (“CDC”) had published Clinical Practice Guidelines and Recommendations entitled “Prevention of Perinatal Group B Streptococcal Disease.” The CDC recommendations were based upon critical appraisal of multi-state population-based observational data and several studies from individual institutions. The CDC Guidelines indicated the following:

Obstetric care [providers], in conjunction with supporting laboratories and labor and delivery facilities, should adopt the following strategy for the prevention of perinatal GBS disease based on prenatal screening for GBS colonization. The risk-based approach is no longer an *451 acceptable alternative except for circumstances in which screening results are not available before delivery. All pregnant women should be screened at 35-37 weeks’ gestation for vaginal and rectal GBS colonization. At the time of labor or the rupture of membranes, intrapar-tum chemoprophylaxis should be given to all pregnant women identified as GBS carriers. [Emphasis supplied.]

The American College of Obstetricians and Gynecologists (“ACOG”) adopted the CDC Recommendations and Guidelines, issuing the following statement:

The [ACOG] has issued new recommendations calling for universal screening of pregnant women for [GBS], a leading cause of illness and death among newborns in the United States. Previously, ACOG and other experts had recommended two options for identifying women with GBS: either a culture screening at 35-37 weeks of pregnancy or assessment of clinical risk factors at the time of labor.... The change in clinical practice follows new data and recommendations from the federal Centers for Disease Control and Prevention (CDC) that show routine prenatal screening is significantly more effective than the risk-based approach, resulting in far fewer cases of early-onset GBS disease in newborns (occurring during the first week of life). In light of the new data, the risk-based strategy, except in certain circumstances, is no longer an acceptable alternative.... The committee opinion supports the CDC’s newly revised guidelines that create a screening-based approach for the prevention of early onset GBS disease in the newborn be adopted. [Emphasis supplied.]

The American Academy of Pediatrics (“AAP”) also adopted the CDC guidelines and issued a physician statement endorsement: “The [AAP] endorses and accepts as its policy the sections of this Statement as it relates to infants and children.” The report was published in August 2002.

Despite the foregoing, Ashraf asserted that neither Dr. Ahmad, her obstetrician, nor Trinity performed the prenatal GBS testing and screening on her. As a result, the GBS colonization of Ashraf s birth canal was not identified, prophylactic antibiotic therapy was not administered during labor, and Inaya contracted a GBS infection at birth suffering a multitude of complications.

Ashraf sued Trinity, alleging that Trinity’s failure to adopt, implement, and enforce the universal GBS culture-based screening protocol, as recommended by the CDC, ACOG, and AAP, was a breach of the standard of care and that she and Inaya were damaged as a result.

In support of these allegations, Ashraf filed three expert reports — an original by Dr. Hunter Hammill, an addendum to the Hammill report, and a report by hospital consultant Arthur S. Shorr. Regarding causation, the original Hammill report said in part:

[T]he injuries to [Inaya] were directly related to [Dr. Ahmad’s] failure to follow the standard of care in place in August 2003. In reasonable medical probability, [Ashraf s] GBS colonization would likely have been identified had Dr. Ahmad ordered the requisite GBS culture screen, and thereafter, prophylactic antibiotic therapy during labor would have prevented [Ashrafs] GBS infection. Dr. Ahmad’s failure to follow the standard of care caused [Inaya’s] respiratory distress, cyanosis, pneumonia, and other injuries she sustained at birth due to early onset GBS. [Emphasis supplied.]

Dr. Hammill’s addendum to his original report said in part:

*452 In reasonable medical probability, [Ash-rafs] GBS colonization would likely have been identified had [Trinity] adopted, implemented, and enforced the requisite GBS culture screen at the 35-37 weeks; and thereafter, prophylactic antibiotic therapy during labor would have been initiated in response to the positive culture, and would have prevented [Inaya’s] GBS infection. [Trinity’s] negligence in failing to require its obstetricians practicing within its facility to follow a universal GBS culture-based screening protocol and further failure to require the administration of prophylactic antibiotics (Penicillin) therapy during labor, in the absence of GBS culture status results, was negligent and such negligence was a proximate cause of [Inaya’s] respiratory distress, cyanosis, pneumonia, and other injuries sustained at birth due to early onset GBS. [Emphasis supplied.]

Trinity asserts that the Hammill addendum did little to elaborate on the subject of causation because it merely stated that the hospital’s failure to require Dr. Ahmad to employ universal screening and administer prophylactic antibiotics was negligent and that “such negligence was a proximate cause of [Inaya’s] respiratory distress, cya-nosis, pneumonia, and other injuries she sustained at birth due to early onset GBS,” and that this was insufficient.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Steven Douglas Pedro, M.D. v. Sherrie R. Lake
Court of Appeals of Texas, 2017
Nexion Health at Duncanville, Inc. v. Ross
374 S.W.3d 619 (Court of Appeals of Texas, 2012)
Neason v. Buckner
352 S.W.3d 254 (Court of Appeals of Texas, 2011)
Certified EMS, Inc. v. Potts
355 S.W.3d 683 (Court of Appeals of Texas, 2011)
Taylor v. Fossett
320 S.W.3d 570 (Court of Appeals of Texas, 2010)
Fagadau v. Wenkstern
311 S.W.3d 132 (Court of Appeals of Texas, 2010)
Foster v. Richardson
303 S.W.3d 833 (Court of Appeals of Texas, 2009)
Daniel L. Foster, D.O. v. Mary Richardson
Court of Appeals of Texas, 2009

Cite This Page — Counsel Stack

Bluebook (online)
224 S.W.3d 448, 2007 WL 174417, Counsel Stack Legal Research, https://law.counselstack.com/opinion/farishta-v-tenet-healthsystem-hospitals-dallas-inc-texapp-2007.